Nanoparticle–chelator conjugates as inhibitors of amyloid-β aggregation and neurotoxicity: A novel therapeutic approach for Alzheimer disease
- 22 May 2009
- journal article
- research article
- Published by Elsevier BV in Neuroscience Letters
- Vol. 455 (3), 187-190
- https://doi.org/10.1016/j.neulet.2009.03.064
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Oxidative stress activates a positive feedback between the γ‐ and β‐secretase cleavages of the β‐amyloid precursor proteinJournal of Neurochemistry, 2007
- Iron: The Redox-active Center of Oxidative Stress in Alzheimer DiseaseNeurochemical Research, 2007
- Therapeutic Treatments for Alzheimer's Disease Based on Metal BioavailabilityDrug News & Perspectives, 2006
- Therapeutic approaches to protein-misfolding diseasesNature, 2003
- Electron microscopic analysis of nanoparticles delivering thioflavin-T after intrahippocampal injection in mouse: implications for targeting β-amyloid in Alzheimer's diseaseNeuroscience Letters, 2003
- Inhibitors of Fibril Formation and Cytotoxicity of β-Amyloid Peptide Composed of KLVFF Recognition Element and Flexible Hydrophilic Disrupting ElementBiochemical and Biophysical Research Communications, 2002
- Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative StressJournal of Neurochemistry, 1998
- Oxidative Stress Hypothesis in Alzheimer's DiseaseFree Radical Biology & Medicine, 1997
- The Role of Iron in Beta Amyloid ToxicityBiochemical and Biophysical Research Communications, 1995
- Vitamin E protects nerve cells from amyloid βprotein toxicityBiochemical and Biophysical Research Communications, 1992